A case of newly diagnosed metastatic pancreatic cancer presenting with associated immune thrombocytopenic purpura.
Metastatic pancreatic adenocarcinoma presenting with immune thrombocytopenic purpura is a very rare association. To date, only 1 case report found in the literature delineates such an association. We present a case of a patient with newly diagnosed, biopsy-proven metastatic pancreatic adenocarcinoma with new-onset immune thrombocytopenic purpura. The patient's platelet count returned to normal limits after being treated with oral corticosteroid therapy. In conclusion, immune thrombocytopenic purpura can be associated with metastatic pancreatic adenocarcinoma and responds well to corticosteroid therapy.
Varma
Adarsh
A
University of Wisconsin Hospitals and Clinics, Department of Internal Medicine, USA.
Spier
Bret J
BJ
Pfau
Patrick R
PR
Safdar
Nasia
N
D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000175:diagnosis*; D011696:Purpura, Thrombocytopenic / Q000150:complications* / Q000175:diagnosis*